z-logo
Premium
Re: The average Adjusted Symptom Score, a new primary efficacy end‐point for specific allergen immunotherapy trials
Author(s) -
Valenti D.
Publication year - 2012
Publication title -
clinical and experimental allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 154
eISSN - 1365-2222
pISSN - 0954-7894
DOI - 10.1111/j.1365-2222.2012.03989.x
Subject(s) - medicine , clinical trial , citation , immunotherapy , end point , guideline , clinical endpoint , family medicine , library science , computer science , pathology , cancer , real time computing

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom